HLA-Dependent TNF Secretory Response May Provide an Immunogenetic Link Between Pre-Eclampsia and Type 1 Diabetes Mellitus

Disease Markers

Volumn 13, Issue 1, 1996, Pages 43-47

  Kilpatrick, David C ^a  

^a Department of Transfusion Medicine ^*  (United Kingdom)

Author keywords

Tumour necrosis factor HLA DR Diabetes Pre eclampsia

Indexed keywords

HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0029790965     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/1996/469613     Document Type: Article

References (16)

1. Bendtzen, K., Morling, N., Fomsgaard, A., Svenson, M., Jakobsen, B., Odum, N., Svejaard, A. (1988). Association between HLA-DR2 and production of tumour necrosis factor a and interleukin 1 by mononuclear cells activated by lipopolysaccharide.Sam J. Immunol., 28, 599–606.
2. Cooper, D.W., Brennecke, S.P., Wilton, A.N. (1993). Genetics of pre-eclampsia. Hypertension in Pregnancy, 12, 1–23.
3. Dahlquist, G., Källén, B. (1992). Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset Type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 35, 671–675.
4. Garner, P.R., d’Alton, M.E., Dudley, D.K., Huard, P., Hardie, M. (1990). Pre-eclampsia in diabetic pregnancies. Am. J. Obstet. Gynecol., 163, 505–508.
5. Hayward, C., Gilfillan, A., Livingstone, J., Adam, M., McIntosh, I., Brock, D.J.H. (1990). HLA-DR and pre-eclampsia in Edinburgh. Lancet, 335, 1458–1459.
6. Hayward, C, Livingstone, J., Holloway, S., Liston, W.A., Brock, D.J.H. (1992). An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am. J. Hum. Genet., 50, 749–758.
7. Jacob, C.O., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A., McDevitt, H.O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sei. USA, 87, 1233–1237.
8. Jazwinska, E.C., Kilpatrick, D.C., Smart, G.E., Liston, W.A. (1987). Feto-maternal HLA compatibility does not have a major influence on human pregnancy except for lymphocytotoxin production. Clin. Exp. Immunol., 69, 116–122.
9. Kilpatrick, D.C., Gibson, F., Livingstone, J., Liston, W.A. (1990). Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus. Tissue Antigens, 35, 178–181.
10. Liston, W.A., Kilpatrick, D.C. (1991). Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br. J. Obstet. Gynaecol., 98, 1079–1086.
11. Peces, R., Urra, J.M., de la Torre, M. (1995). Influence of HLA-DR phenotype on tumour necrosis factor-alpha production in renal transplant recipients. Nephron, 71, 180–183.
12. Pociot, F., Briant, L., Jongeneel, C.V., Mölvig, J., Worsaae, H., Abbal, M., Thomsen, M. Nerup, J., Cambon-Thomsen, A. (1993). Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFa and TNFß by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol, 23, 224–231.
13. Santamaria, P., Gehry, R.C., Bryan, M.K., Barbosa, J.J. (1989). Involvement of Class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. J. Immunol., 143, 913–922.
14. Simon, P., Fauchet, R., Pilorge, M., Calvery, C., Le Fiblec, B., Cam, G., Ang, K.S., Genetet, B., Cloup, B. (1988). Association of HLA-DR4 with the risk of recurrence of pregnancy hypertension. Kid Int., 34, Suppl. 25, 5125–5128.
15. Stark, J.M. (1993). Pre-eclampsia and cytokine induced oxidative stress. Br. J. Obstet. Gynaecol., 100, 105–109.
16. Wilton, A.N., Barendse, W.J., Donald, J.A., Marshall, P., Trudinger, B., Gallery, E.D.M., Brennecke, S.P., Cooper, D.W. (1991). HLA-DRß types in pre-eclampsia and eclampsia. Tissue Antigens, 38, 137–141.